Reddy, K R <br/><br/>
Peginterferon alpha-2a (40 kDa) and ribavirin: comparable rates of sustained virological response in sub-sets of older and younger HCV genotype 1 patients.  [electronic resource] 

 -  Journal of viral hepatitis  Oct 2009 
 - 724-31 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1365-2893 
<br/><br/><label>Standard No.: </label>10.1111/j.1365-2893.2009.01122.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Age Factors<br/>Antiviral Agents--therapeutic use<br/>Female<br/>Genotype<br/>Hepacivirus--classification<br/>Hepatitis C, Chronic--drug therapy<br/>Humans<br/>Interferon alpha-2<br/>Interferon-alpha--administration & dosage<br/>Male<br/>Middle Aged<br/>Polyethylene Glycols--administration & dosage<br/>Recombinant Proteins<br/>Ribavirin--administration & dosage<br/>Secondary Prevention<br/>Treatment Outcome